Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock

135.92  +2.05 (+1.53%)

After market: 135.92 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ADUS. ADUS was compared to 108 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making ADUS a very profitable company, without any liquidiy or solvency issues. ADUS is growing strongly while it is still valued neutral. This is a good combination! With these ratings, ADUS could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
ADUS had a positive operating cash flow in the past year.
In the past 5 years ADUS has always been profitable.
Each year in the past 5 years ADUS had a positive operating cash flow.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

ADUS has a Return On Assets of 6.39%. This is amongst the best in the industry. ADUS outperforms 88.78% of its industry peers.
ADUS has a better Return On Equity (7.77%) than 72.90% of its industry peers.
ADUS has a better Return On Invested Capital (7.89%) than 76.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ADUS is in line with the industry average of 8.27%.
The last Return On Invested Capital (7.89%) for ADUS is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.39%
ROE 7.77%
ROIC 7.89%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 6.50%, ADUS belongs to the top of the industry, outperforming 85.05% of the companies in the same industry.
ADUS's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 9.03%, ADUS belongs to the best of the industry, outperforming 82.24% of the companies in the same industry.
ADUS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 32.15%, ADUS is in line with its industry, outperforming 57.94% of the companies in the same industry.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.03%
PM (TTM) 6.5%
GM 32.15%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADUS is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
ADUS has more shares outstanding than it did 5 years ago.
ADUS has a better debt/assets ratio than last year.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

ADUS has an Altman-Z score of 8.99. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
ADUS has a better Altman-Z score (8.99) than 93.46% of its industry peers.
ADUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.99
ROIC/WACC0.87
WACC9.1%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.11 indicates that ADUS has no problem at all paying its short term obligations.
ADUS has a better Current ratio (2.11) than 72.90% of its industry peers.
ADUS has a Quick Ratio of 2.11. This indicates that ADUS is financially healthy and has no problem in meeting its short term obligations.
ADUS has a Quick ratio of 2.11. This is in the better half of the industry: ADUS outperforms 74.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

ADUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.47%, which is quite impressive.
Measured over the past years, ADUS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.26% on average per year.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
The Revenue has been growing by 15.43% on average over the past years. This is quite good.
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y18.26%
EPS Q2Q%13.04%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Sales Q2Q%7.04%

3.2 Future

ADUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.05% yearly.
The Revenue is expected to grow by 12.82% on average over the next years. This is quite good.
EPS Next Y16.23%
EPS Next 2Y15.73%
EPS Next 3Y15.05%
EPS Next 5YN/A
Revenue Next Year8.35%
Revenue Next 2Y16.22%
Revenue Next 3Y12.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.24, ADUS can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ADUS is valued a bit cheaper than the industry average as 63.55% of the companies are valued more expensively.
ADUS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.29.
The Price/Forward Earnings ratio is 22.50, which indicates a rather expensive current valuation of ADUS.
Based on the Price/Forward Earnings ratio, ADUS is valued a bit cheaper than the industry average as 61.68% of the companies are valued more expensively.
ADUS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.24
Fwd PE 22.5
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA is on the same level as the industry average.
ADUS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 74.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.5
EV/EBITDA 18.95
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ADUS may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 15.05% in the coming years.
PEG (NY)1.62
PEG (5Y)1.44
EPS Next 2Y15.73%
EPS Next 3Y15.05%

More info and screens

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADDUS HOMECARE CORP

NASDAQ:ADUS (1/21/2025, 6:35:08 PM)

After market: 135.92 0 (0%)

135.92

+2.05 (+1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners100.83%
Inst Owner Change-0.2%
Ins Owners1.75%
Ins Owner Change0.67%
Market Cap2.46B
Analysts84.44
Price Target142.43 (4.79%)
Short Float %2.83%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.16%
Min EPS beat(2)-0.68%
Max EPS beat(2)9%
EPS beat(4)3
Avg EPS beat(4)6.88%
Min EPS beat(4)-0.68%
Max EPS beat(4)10.37%
EPS beat(8)7
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)11
Avg EPS beat(16)4.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.49%
Min Revenue beat(4)-1.83%
Max Revenue beat(4)-1.28%
Revenue beat(8)0
Avg Revenue beat(8)-1.26%
Revenue beat(12)0
Avg Revenue beat(12)-1.69%
Revenue beat(16)0
Avg Revenue beat(16)-2.15%
PT rev (1m)0.75%
PT rev (3m)4.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.48%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 26.24
Fwd PE 22.5
P/S 2.17
P/FCF 19.5
P/OCF 18.11
P/B 2.6
P/tB 12.48
EV/EBITDA 18.95
EPS(TTM)5.18
EY3.81%
EPS(NY)6.04
Fwd EY4.44%
FCF(TTM)6.97
FCFY5.13%
OCF(TTM)7.5
OCFY5.52%
SpS62.54
BVpS52.27
TBVpS10.89
PEG (NY)1.62
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 6.39%
ROE 7.77%
ROCE 10.29%
ROIC 7.89%
ROICexc 10.16%
ROICexgc 356.56%
OM 9.03%
PM (TTM) 6.5%
GM 32.15%
FCFM 11.15%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%
ROICexc(3y)8.47%
ROICexc(5y)7.58%
ROICexgc(3y)87.71%
ROICexgc(5y)69.95%
ROCE(3y)9.67%
ROCE(5y)8.41%
ROICexcg growth 3Y24.91%
ROICexcg growth 5Y31.22%
ROICexc growth 3Y10.93%
ROICexc growth 5Y1.53%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%
F-Score7
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 69.13%
Cap/Sales 0.85%
Interest Coverage 13.31
Cash Conversion 116.95%
Profit Quality 171.61%
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 8.99
F-Score7
WACC9.1%
ROIC/WACC0.87
Cap/Depr(3y)52.67%
Cap/Depr(5y)51.52%
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.78%
Profit Quality(3y)150.66%
Profit Quality(5y)158.26%
High Growth Momentum
Growth
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y18.26%
EPS Q2Q%13.04%
EPS Next Y16.23%
EPS Next 2Y15.73%
EPS Next 3Y15.05%
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Sales Q2Q%7.04%
Revenue Next Year8.35%
Revenue Next 2Y16.22%
Revenue Next 3Y12.82%
Revenue Next 5YN/A
EBIT growth 1Y17.51%
EBIT growth 3Y22.58%
EBIT growth 5Y32.37%
EBIT Next Year39.06%
EBIT Next 3Y23.97%
EBIT Next 5YN/A
FCF growth 1Y24.25%
FCF growth 3Y0.06%
FCF growth 5Y29.8%
OCF growth 1Y28.34%
OCF growth 3Y0.86%
OCF growth 5Y27.59%